for people ages 18 years and up (full criteria)
at San Francisco, California and other locations
study started
estimated completion:



The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for acute HF.

Official Title

International Registry to Assess mEdical Practice With lOngitudinal obseRvation for Treatment of Heart Failure


Acute Heart Failure Registry Heart failure Hospitalized Global Morbidity Mortality Quality of life AHF


You can join if…

Open to people ages 18 years and up

Patients at least 18 years old, or older for those countries where the adult age is above 18 years of age, hospitalized with a primary diagnosis of acute heart failure.

You CAN'T join if...

1-Concomitant participation in any/a clinical trial with any investigational treatment (for any sponsor).

  1. Use of investigational drugs within 5 half-lives of enrollment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer.


  • Novartis Investigative Site
    San Francisco California 94143-0780 United States
  • Novartis Investigative Site
    San Diego California 92103 United States


in progress, not accepting new patients
Start Date
Completion Date
Novartis Pharmaceuticals
Study Type
Observational [Patient Registry]
Last Updated